Related references
Note: Only part of the references are listed.Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
Heidi Fiegl et al.
CLINICAL CANCER RESEARCH (2008)
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
Eiji Sunami et al.
BREAST CANCER RESEARCH (2008)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
Weiwei Feng et al.
BREAST CANCER RESEARCH (2007)
Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients
Zhao Hui Huang et al.
CANCER LETTERS (2006)
Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer
Mohammad O. Hoque et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients
Nan Soon Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR
Maria Ntoulia et al.
CLINICAL BIOCHEMISTRY (2006)
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients
Nikos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support
Miguel Quintela-Fandino et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients
Kazuo Koyanagi et al.
CANCER RESEARCH (2006)
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer
Ina H. Benoy et al.
CLINICAL BREAST CANCER (2006)
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
P Wülfing et al.
CLINICAL CANCER RESEARCH (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells
T Fehm et al.
CYTOTHERAPY (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients
H Fiegl et al.
CANCER RESEARCH (2005)
Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer
O Topaloglu et al.
CLINICAL CANCER RESEARCH (2004)
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
S Gal et al.
BRITISH JOURNAL OF CANCER (2004)
DNA methylation in serum and tumors of cervical cancer patients
A Widschwendter et al.
CLINICAL CANCER RESEARCH (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer
MO Hoque et al.
CANCER RESEARCH (2004)
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
M Widschwendter et al.
CANCER RESEARCH (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Detection of hypermethylated genes in tumor and plasma of cervical cancer patients
HJ Yang et al.
GYNECOLOGIC ONCOLOGY (2004)
DNA methylation and breast carcinogenesis
M Widschwendter et al.
ONCOGENE (2002)
Quantitative assessment of promoter hypermethylation during breast cancer development
U Lehmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Pitfalls in the detection of disseminated non-hematological tumor cells
JC Goeminne et al.
ANNALS OF ONCOLOGY (2000)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
